ID: ALA3973492

Max Phase: Preclinical

Molecular Formula: C16H14N2O2

Molecular Weight: 266.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(NCc2cc3ccccc3nc2O)cc1

Standard InChI:  InChI=1S/C16H14N2O2/c19-14-7-5-13(6-8-14)17-10-12-9-11-3-1-2-4-15(11)18-16(12)20/h1-9,17,19H,10H2,(H,18,20)

Standard InChI Key:  KTQNASMGONZFNN-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrolipoyl dehydrogenase 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.30Molecular Weight (Monoisotopic): 266.1055AlogP: 3.26#Rotatable Bonds: 3
Polar Surface Area: 65.38Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.27CX Basic pKa: 5.15CX LogP: 3.32CX LogD: 3.31
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: -0.80

References

1.  (2015)  Compounds and methods for treating tuberculosis infection, 

Source

Source(1):